Diagnostic Image Quality and Safety of Low-Volume, Low-Concentration, Iso-Osmolar Contrast Medium in the Computed Tomographic Workup of Patients Considered for TAVR
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Iodixanol (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- 21 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 16 Apr 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Dec 2016, according to to ClinicalTrials.gov record.
- 16 Apr 2015 Status changed from recruiting to active, no longer recruiting, according to to ClinicalTrials.gov record.